
Dasanix100 mg
Beacon Pharmaceuticals PLC
Dasatinib is a tyrosine kinase inhibitor (TKI) approved for the treatment of certain Philadelphia chromosome-positive (Ph+) leukemias.
Dasatinib is a tyrosine kinase inhibitor (TKI) approved for the treatment of certain Philadelphia chromosome-positive (Ph+) leukemias. Its use is classified by strength of evidence as follows:
Dasatinib is sometimes used off-label in other BCR-ABL-driven or SRC-kinase-driven conditions under specialist oncology guidance; such use is not FDA-approved and should only occur within a clinical trial or specialist protocol.
| Indication | Recommended dose |
|---|---|
| Chronic phase Ph+ CML (newly diagnosed or prior therapy) | 100 mg orally once daily |
| Accelerated, myeloid, or lymphoid blast phase Ph+ CML | 140 mg orally once daily |
| Ph+ acute lymphoblastic leukemia (ALL) | 140 mg orally once daily |
Dosing is weight-based for patients 1 year and older, using tablets or oral suspension as appropriate, generally ranging from about 40 mg to 100 mg once daily depending on body weight band; exact dose must be individualized by a pediatric oncologist per current weight-based dosing tables.
Dose interruption, reduction, or discontinuation is required for severe myelosuppression (neutropenia, thrombocytopenia), non-hematologic toxicity, QT prolongation, or fluid retention, as determined by the treating physician based on blood counts and clinical status.
No formal dose adjustment has been firmly established for renal impairment; use with caution and physician monitoring. In hepatic impairment, use with caution as hepatic metabolism may be altered; consult a physician for individualized dosing.
Dasatinib is contraindicated in patients with known hypersensitivity to dasatinib or any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.